NFE2L2 and hypertensive disorder: It is reported that microinjection IL-1beta into the RVLM decreases the expressions of p-Nrf2, which regulates mitochondrial biogenesis and participates in the pathogenesis of hypertension induced by systemic inflammation (Wu et al., 2016).